Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AdvisorShares Trust AdvisorShares Pure US Cannabis ETF (NY:MSOS)

4.400 -0.230 (-4.97%)
Streaming Delayed Price Updated: 3:26 PM EDT, Oct 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AdvisorShares Trust AdvisorShares Pure US Cannabis ETF

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Is Now the Time to Finally Buy Pot Stocks Again?
The potential for cannabis reform has made investors bullish on the industry in recent weeks. 
Via The Motley Fool
Topics Cannabis ETFs Government
1 Major Reason Cannabis Stocks Surged This Week
President Trump's social media feed put the markets in a frenzy. 
Via The Motley Fool
Topics Cannabis ETFs Government
President Trump Lights Up Cannabis Stocks With Pro-CBD Truth Social Post
President Donald Trump posted a video on Truth Social on Sunday, promoting the potential health benefits of cannabis. Cannabis stocks lit up on Monday after Trump resurrected hopes for a change in... 
Via Benzinga
Topics Cannabis Government
Microcap Cannabis Stock VFF Is Having A ‘Trump Pump’ Moment — And Retail Traders Feel Bullish Ahead Of Q2 Earnings
Via Stocktwits
Topics Cannabis
Turnaroud Tuesday: Did Canna Finally Bottom?
MSOS rose over 14% in today’s session. Interestingly, the price action was inside the trading range of Monday. 
Via Talk Markets
Is Tilray Brands a Dirt Cheap Growth Stock or Just a Bad Buy?
Shares of the cannabis producer have been rallying, but they are still nowhere near the levels they were at a few years ago. 
Via The Motley Fool
Topics Cannabis ETFs
EXCLUSIVE: Cannabis ETF Leaders Highlight Convenience For Investors, Growth Opportunities — 'I Don't Think Cannabis Is Uninvestable'
Cannabis ETFs have been hurt by a sector that didn't get the expected federal reform many investors expected over the past five years. Experts share what could come next. 
Via Benzinga
Topics Cannabis ETFs
Hedge Fund Veteran Doug Kass Says Most Cannabis Stocks Are 'Walking Dead,' But These 4 Names Stand Out
Doug Kass says most cannabis stocks are ‘walking dead' — but highlights Trulieve, GTI, TerrAscend and Glass House as top picks for patient investors. 
Via Benzinga
Topics Cannabis
This Week In Cannabis: Trump's Reform Buzz Drives Stocks Up, RAW's Secret Factory, Global Shifts And More
Cannabis stocks rally, RAW opens its factory, Portugal leads EU exports, here's what happened this week. 
Via Benzinga
Topics Cannabis Government
Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp'
Cannabis stocks jumped as Trump reportedly pushes SAFE Banking behind the scenes—but analysts warn: don't chase the hype just yet. 
Via Benzinga
Topics Cannabis Government
The One-Minute Market Report - Saturday, April 19
In this brief market report, we will take a look at the various asset classes, sectors, equity categories, ETFs, and stocks that moved the market higher, as well as the market segments that defied the... 
Via Talk Markets
Topics ETFs Stocks / Equities
1 Underrated Growth Industry That Could Be Well Protected Against Tariffs
Via The Motley Fool
Topics Cannabis Economy Law Enforcement
What Sparked The Cannabis Stock Rally On Thursday?
Cannabis stocks blazed higher on Thursday after Former Rep. Matt Gaetz (R-Fla.) reportedly said cannabis reform is "on the horizon." 
Via Benzinga
Topics Cannabis
The One-Minute Market Report - Saturday, March 15
In this brief market report, we will take a look at the various asset classes, sectors, equity categories, ETFs, and stocks that moved the market higher, as well as the market segments that defied the... 
Via Talk Markets
Topics ETFs Stocks / Equities
AdvisorShares Unveils HVAC ETF, Betting On Growth In Climate Control And Infrastructure
AdvisorShares launched HVAC & Industrials ETF on Feb. 4, investing in HVAC & industrial companies for long-term growth. Portfolio includes ADRs. 
Via Benzinga
Topics ETFs
Tilray Brands Has Diversified Its Business Through Alcohol, but Is the Stock a Better Buy Than It Was 5 Years Ago?
Via The Motley Fool
Cannabis Legalization Headed For The Ballot Again In Florida: Advocates Launch New Amendment Initiative
Group behind failed attempt to legalize recreational cannabis in FL has launched new initiative for 2026 ballot. Allows adult use with limits and restrictions. 
Via Benzinga
Topics Cannabis
Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector
Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA's indecisiveness. 
Via Benzinga
Topics Cannabis ETFs
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop. 
Via Benzinga
Topics Cannabis
Here's Why Tilray Brands' CEO Is Optimistic Marijuana Legalization Will Happen Under the Trump Administration
Via The Motley Fool
Topics Cannabis Government
Cannabis Reform 2024: The Year Of All Talk And No Action
In 2024, the cannabis landscape in the U.S. experienced some developments, though federal legalization or removal from the CSA. 
Via Benzinga
Topics Cannabis
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance. 
Via Benzinga
Topics Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56. 
Via Benzinga
Topics Cannabis ETFs Government
Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment. 
Via Benzinga
Topics Cannabis Government
Matt Gaetz Is Trump's Attorney General Pick: Would-Be Top Cop Is Under House Ethics Investigation
Matt Gaetz has been named the attorney general nominee by Donald Trump. The selection comes while Gaetz is being investigated by Congress. 
Via Benzinga
Topics Government
Stocks Of The Day: 4-Pillar Power Plays You Can’t Miss - Today’s Biggest Movers
Markets opened with a strong tailwind, driven by the latest CPI data showing inflation in line with expectations, bolstering investor confidence. 
Via Talk Markets
Topics Economy
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%. 
Via Benzinga
Topics Cannabis Government
The Good, The Bad, And The Ugly: A Recap Of Post-Vote Winners & Losers
What’s promised on the campaign trail and what comes to reality are often different. But that didn’t stop investors and traders from speculating on the most prevalent themes under a new administration.... 
Via Talk Markets
Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?
After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip? 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.